PA Consulting Group's medical device development team exhibited at the RDD Europe 2011 event in Berlin, Germany, 3 to 6 May 2001 with a focus on 'The future of drug delivery product development: closing the loop between treatment and patient response'.
Sarah Wren, and other PA experts in healthcare technology, were on hand throughout the event to discuss strategy scenarios for those dealing with drug-device combination product development, including such issues as:
-
how future device development will be impacted by the far reaching reforms fundamentally changing the relationships between key players across the world of healthcare
-
the key drivers for the future, such as using information to create more personalised care and standardisation at the same time; thereby increasing access, driving up quality and reducing the cost of overall care and PA will be showing concepts for future inhalation products. For a preview video please visit here.
Through our global pharmaceutical and technology consultancy services, we support drug product development, device development, manufacturing and supply chain optimisation, commercial strategy and operations. We help organisations gain competitive advantage through all aspects of the effective delivery of new healthcare products and services.
For more information about PA's exhibit contact Sarah Wren.
To find out more about PA's healthcare capability, contact us now or visit here.
For more about PA's approach to drug delivery, please visit here.
PRINT
EMAIL
TWITTER
LINKEDIN
FACEBOOK
FEEDS